Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease

被引:47
作者
Deeva, Irina [1 ]
Mariani, Serena [1 ]
De Luca, Chiara [1 ]
Pacifico, Valeria [2 ]
Leoni, Luca [2 ]
Raskovic, Desanka [2 ]
Kharaeva, Zaira [3 ]
Korkina, Liudmila [1 ]
Pastore, Saveria [1 ]
机构
[1] IDI IRCCS, Lab Tissue Engn & Cutaneous Physiopathol, I-00167 Rome, Italy
[2] IDI IRCCS, Dermatol Div 2, I-00167 Rome, Italy
[3] Med Univ Kabardino Balkaria, Dept Immunol, Nalchik 360000, Russia
关键词
Cytokine; Chemokine; Growth factor; Psoriasis; INTERLEUKIN-1 RECEPTOR ANTAGONIST; GROWTH-FACTOR RECEPTORS; NECROSIS-FACTOR-ALPHA; INCREASED EXPRESSION; HUMAN KERATINOCYTES; METABOLIC SYNDROME; CLINICAL-FEATURES; ATOPIC-DERMATITIS; SERUM-LEVELS; TNF-ALPHA;
D O I
10.1016/j.cyto.2009.09.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Psoriasis is a chronic recurrent inflammatory disorder of the skin. Clinical subtypes include psoriasis vulgaris (PV), psoriatic arthropathy, and erythrodermic psoriasis. Aim of this study was to analyse relevant inflammatory mediators in the plasma of patients with distinct subtypes of active psoriasis, and in the scales of mild-to-moderate PV patients, and correlation to disease severity. Compared to healthy controls (n = 10), patients affected by very severe forms of psoriasis (n = 30) were characterized by increased plasma levels of 114, IL-6, MCP-1, VEGF and in particular PDGFbb. Each group with severe psoriasis had distinct characteristic features of plasma cytokine profile. Mild-to-moderate PV patients (n = 35) showed higher levels of IL-4, IL-6, IL-10, and IL-13 when compared to healthy controls. No correlation was found between PV severity assessed by PASI (Psoriasis Area and Severity Index) and levels of these mediators. By contrast. disease severity correlated to scale levels of IP-10. For the first time, we found exaggerated circulating levels of the pro-angiogenic PDGFbb and VEGF in severe psoriasis. Evidence that the severity of skin symptoms correlated exclusively with scale levels of IP-10, but not with any up-regulated inflammatory mediator in plasma, suggests that distinct skin-independent processes contribute to the circulating cytokine profile in psoriasis. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 46 条
[1]   HUMAN KERATINOCYTES ARE A MAJOR SOURCE OF CUTANEOUS PLATELET-DERIVED GROWTH-FACTOR [J].
ANSEL, JC ;
TIESMAN, JP ;
OLERUD, JE ;
KRUEGER, JG ;
KRANE, JF ;
TARA, DC ;
SHIPLEY, GD ;
GILBERTSON, D ;
USUI, ML ;
HART, CE .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :671-678
[2]   Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity [J].
Arican, O ;
Aral, M ;
Sasmaz, S ;
Ciragil, P .
MEDIATORS OF INFLAMMATION, 2005, (05) :273-279
[3]   Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].
Atkinson, AJ ;
Colburn, WA ;
DeGruttola, VG ;
DeMets, DL ;
Downing, GJ ;
Hoth, DF ;
Oates, JA ;
Peck, CC ;
Schooley, RT ;
Spilker, BA ;
Woodcock, J ;
Zeger, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95
[4]   Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion [J].
Ayache, Saleh ;
Panelli, Monica C. ;
Byrne, Karen M. ;
Slezak, Stefanie ;
Leitman, Susan F. ;
Marincola, Francesco M. ;
Stroncek, David F. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2006, 4 (1)
[5]   INTERLEUKIN-1 RECEPTOR ANTAGONIST PRODUCTION BY HUMAN KERATINOCYTES [J].
BIGLER, CF ;
NORRIS, DA ;
WESTON, WL ;
AREND, WP .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (01) :38-44
[6]  
Boniface K, 2005, EUR CYTOKINE NETW, V16, P309
[7]  
de Vlam K, 2008, J RHEUMATOL, V35, P1443
[8]   ENHANCED PRODUCTION OF BIOLOGICALLY-ACTIVE INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA BY PSORIATIC EPIDERMAL-CELLS EX-VIVO - EVIDENCE OF INCREASED CYTOSOLIC INTERLEUKIN-1-BETA LEVELS AND FACILITATED INTERLEUKIN-1 RELEASE [J].
DEBETS, R ;
HEGMANS, JPJJ ;
TROOST, RJJ ;
BENNER, R ;
PRENS, EP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) :1624-1630
[9]   Localization of monocyte chemotactic and activating factor (MCAF/MCP-1) in psoriasis [J].
Deleuran, M ;
Buhl, L ;
Ellingsen, T ;
Harada, A ;
Larsen, CG ;
Matsushima, K ;
Deleuran, B .
JOURNAL OF DERMATOLOGICAL SCIENCE, 1996, 13 (03) :228-236
[10]   Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis [J].
Doecke, Wolf-Dietrich ;
Asadullah, Khusru ;
Belbe, Gudrun ;
Ebeling, Merle ;
Hoeflich, Conny ;
Friedrich, Markus ;
Sterry, Wolfram ;
Volk, Hans-Dieter .
JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 85 (03) :582-593